True, experts advise not to pay too much attention only to certain foods – the most important thing is a balanced and varied diet. However, adding avocados to your diet can be a healthy choice.
Diabetes is an insidious disease. Often it has no symptoms, and the patient already feels the complications of diabetes – symptoms of damage to nerve endings, myocardial infarction or stroke caused by large blood vessels.
Made in Mexico study published in the Journal of the Academy of Nutrition and Dieteticsshowed a possible link between avocado consumption and a lower risk of diabetes.
Diabetes is the second leading cause of death in Mexico, where about 15.2 percent of the population has the disease. adults (12.8 million people).
To investigate the link between avocado consumption and diabetes risk, researchers examined questionnaires filled out by a portion of the Mexican population in which they provided information about their eating habits and diabetes diagnosis. Most of the survey participants fell into the overweight or obese groups.
The results revealed that women who eat avocados are less likely to develop diabetes. True, such a connection was not observed in men’s answers.
How did the investigation go?
In order to determine people’s avocado consumption habits, survey participants had to complete a seven-day dietary questionnaire. The participants were strictly divided into two groups: avocado consumers (eating any amount of avocados) and non-consumers.
Information about the diagnosis of diabetes mellitus was provided by the people themselves. It is true that only a part of the respondents shared the blood sugar measurements confirming the diagnosis.
Participants also self-reported their demographic and cardiometabolic risk factors, such as age, gender, socioeconomic status, education, body mass index (BMI), obesity, Healthy Eating Index (HEI-2015) score, caloric intake, lifestyle habits and other diagnosed diseases.
The height, weight and waist circumference of the respondents were measured by specially trained personnel.
After collecting the survey data, the researchers analyzed it using descriptive statistics and logistic regression models to examine the association between avocado consumption and diabetes risk.
Benefits of avocados for women
About 45 percent participants reported consuming avocados. Their average daily dose was 34.7 g for men and 29.8 g for women.
Respondents who ate avocados were generally more educated and belonged to a higher socioeconomic class than those who did not consume avocados.
Additionally, more than three-quarters of avocado lovers lived in cities.
Avocado eaters of both sexes also had slightly higher Healthy Eating Index scores, indicating a slightly more nutritious diet overall.
Women who ate avocados had a 22 percent lower risk, even after adjusting for other factors. lower risk of developing diabetes. The same effect was not observed in men.
Avocados and Diabetes – What’s the Connection?
“There are several explanations for why eating avocados may reduce the risk of diabetes in women. One is antioxidants, which reduce inflammation and cell damage, factors that increase the risk of diseases such as diabetes. Rich in fat and fiber, avocados also have a low glycemic index, so they don’t cause the spikes in glucose and insulin levels that disrupt metabolism,” said Dr. Avantika Waring, specialist in endocrinology, diabetes and metabolism.
However, the doctor stressed that these are only hypotheses. Avocados’ high fiber and healthy fats, which promote satiety and lead people to eat less of less nutritious foods, could have this effect, she speculated.
Doctor-scientist dr. Thomas M. Holland of the RUSH Institute for Healthy Aging, which was not involved in the study, also cited the insulin-sensitizing nutrients in avocados that may stabilize the diabetes disease process.
“Now we need to determine exactly why this effect was observed only in women but not in men,” said the expert.
In his opinion, this could be due to a number of factors. Men and women suffer from diabetes differently. This is due to hormonal changes that occur during the course of life, genetic and environmental factors and psychosocial stressors, which increase the risk of diabetes only in women.
Dr. A. Waring did not object to this, emphasizing the significant hormonal changes that women experience during the main stages of life: “During pregnancy, women become more insulin resistant, and during menopause, when the level of estrogen in the blood drops, the composition of women’s body fat changes, which can increase the risk of diabetes.”
Ultimately, it remains unclear what accounts for the differences in the association between avocados and diabetes between men and women. This highlights the need for further research on gender-specific dietary patterns.
There is no data on how much to eat
Dr. who did not participate in the study Eliza Whitaker, a dietitian and nutrition consultant at Dietitian Insights, pointed out a major flaw in the study: the groups into which respondents were divided were too broad, which does not allow us to determine what amount of avocados is the healthiest.
She added that combining occasional and frequent avocado eaters into one group does not allow us to understand the exact effect of this fruit on diabetes risk.
Speaking about what science has already confirmed, the specialist assured: “Avocados may be associated with a lower risk of diabetes, but avocados alone do not protect against diabetes.” To reduce the risk of diabetes as much as possible, we should look at nutrition as a whole.”
Dr. has a similar opinion. Waring, who emphasized that the study encourages eating more unprocessed, heart-healthy foods, including vegetables and fruits, because it improves metabolism. However, the study does not provide specific recommendations for the consumption of avocados.
“A healthy lifestyle, one of the components of which is nutrition, increases a person’s ability to control the course of their disease,” added Dr. TMHolland.
Although such a study is not sufficient to draw strong conclusions about the consumption of avocados and the risk of diabetes, Dr. TMHolland believes that the connection discovered by the Mexican researchers is still significant.
When asked if people should be eating more avocados to reduce their risk of diabetes, the expert said: “Given the abundance and variety of nutrients in avocados, there is compelling evidence that they should be included in healthier diets – such as the DASH diet, the Mediterranean diet or the MIND diet.”
Page page “Medical News Today” inf.
the much-loved fruit protects against a disease that damages blood vessels and causes strokes
Cervical Cancer Elimination: Alabama Leading the Way in Cervical Cancer Prevention
Cervical Cancer Can Be Eliminated. Alabama Is Leading the Way.
Introduction
The fight against cervical cancer has taken a significant stride forward. Alabama, in the southeastern United States, has emerged as a pioneering state in the battle to eliminate this life-threatening disease. With innovative approaches and widespread awareness, Alabama is setting the standard for tackling cervical cancer head-on. Through a combination of vaccination and screening, the state has achieved remarkable progress in the concerted effort to eradicate cervical cancer and provide a healthier future for its population.
Advancements in Human Papillomavirus (HPV) Vaccines
The development of effective Human Papillomavirus (HPV) vaccines has played a pivotal role in the reduction of cervical cancer cases globally. Current research and medical breakthroughs in this area are enabling a wide range of options, ensuring that each individual receives the most suitable vaccine products. Experts assert that personalized vaccination choices contribute to more significant prevention rates and overall disease control. By focusing on individualized vaccine product selection aligned to specific needs, healthcare professionals can elevate the fight against cervical cancer to new heights.
Integrated Approach: HPV Vaccination and Screening
Through the concomitant approach of HPV vaccination and cervical cancer screening, it becomes possible to achieve the ambitious goal of eliminating cervical cancer. Alabama’s implementation of this integrated strategy has paved the way for impressive results. By combining preventative measures such as HPV vaccines with rigorous screening protocols, cervical cancer can be detected at early stages, ensuring timely treatment and a higher chance of positive outcomes. This comprehensive approach becomes a cornerstone in the efforts to limit HPV infections and significantly reduce the burden of cervical cancer.
National Impact: Replicating Alabama’s Success
The success witnessed in Alabama presents an exemplary model that can be adopted nationwide to combat cervical cancer effectively. By promoting widespread access to free HPV vaccines, governments worldwide can ensure that optimal preventive measures are available to all. The expansion of vaccination programs, paired with extensive screening initiatives, allows for the detection, management, and possible eradication of HPV and cervical cancer. The learnings from Alabama’s triumph serve as a catalyst for countries globally to redirect their focus toward the life-saving mission of cervical cancer elimination.
Innovation for a Healthier Future
The elimination of cervical cancer is a long-term vision that necessitates constant innovation. Taking Alabama’s progress as inspiration, researchers continue to explore new directions for improving and refining vaccination methods, screening technologies, and outreach strategies. The combination of innovation, awareness, and policy frameworks will be the driving force behind a healthier future, where cervical cancer will cease to be a widespread health concern.
Cervical Cancer Elimination: Alabama Leading the Way in Cervical Cancer Prevention
Stallergenes Greer Study Shows Significant Reduction in Asthma Risk: EfficAPSI Published in The Lancet – Learn More!
2024-05-06 08:46:14
Stallergenes Greer, a biopharmaceutical laboratory specializing in allergen immunotherapy (ITA), announces the results of its real-world study, EfficAPSI, evaluating the effect of its sublingual ITA solutions on the onset and progression of asthma in patients with allergic rhinitis, was published in the journal The Lancet Regional Health-Europe. This article has already been published online (https://doi.org/10.1016/j.lanepe.2024.100915), will soon be available in print.
This real-life longitudinal and retrospective pharmaco-epidemiological study evaluated, over a period of 9 years, more than 440,000 patients: more than 110,000 patients suffering from allergic rhinitis, with or without asthma, treated with Stallergenes Greer sublingual solutions and symptomatic medications; compared with more than 330,000 patients suffering from allergic rhinitis, with or without asthma, treated only with symptomatic drugs.
The main objective of the study was to evaluate the real effect of Stallergenes Greer sublingual solutions in preventing the onset and exacerbation of asthma in patients with allergic rhinitis. The results of the study are consistent across all age categories (from 5 years), allergens and evaluation criteria.
EfficAPSI showed, in patients treated with Stallergenes Greer sublingual solutions and symptomatic medications, compared to patients treated with only symptomatic medications:
- a 36% reduction in the risk of new asthma attacks across the cohort*;
- a 38% reduction in the risk of developing asthma in patients without existing asthma;
- a reduction by one third in the intensification of treatment recommended within the framework of the Global Initiative for Asthma (GINA), in patients suffering from existing asthma, demonstrating the effectiveness of sublingual solutions in preventing asthma exacerbations.
“I am pleased to communicate this large EfficAPSI study to the medical community through its publication in The Lancet Regional Health-Europe. EfficAPSI confirms the role of sublingual solutions in improving asthma management. The results provide important data on the relevance of sublingual solutions as an etiological treatment which allows personalized treatment, adapted to the unique needs of each individual patient, and offers better clinical outcomes,” declares Professor Pascal Demoly, Head of Pulmonary, Allergy and Thoracic Oncology at Montpellier University Hospital (France), President of the French Society of Allergology, and member by the study’s scientific committee.
“It is important to study the effect of allergen immunotherapy on the onset and progression of asthma. Through this real-world EfficAPSI study, Stallergenes Greer is proud to provide scientific evidence and valuable insight into allergy treatment. We remain focused on developing solutions to alter disease progression , driven by robust clinical data, to redefine the management of respiratory diseases and improve the quality of life of people suffering from allergies.” , says Dr. Elena Rizova, Medical Director of Stallergenes Greer.
By demonstrating their benefits with regard to the onset and exacerbation of asthma, Stallergenes Greer’s sublingual solutions confirm their utility in public health. Stallergenes Greer intends to intensify the use of this approach in real life to strengthen the level of evidence for the benefits of its sublingual ITA treatments. Other criteria are currently under review and will be published later.
Source and image: Stallergenes Greer
*combined score
________________________________
1 Demoly P, Molimard M, Bergmann JF, et al. Effect of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study). Lancet Reg Health Eur. 2024.
2 Demoly P, Corren J, Creticos P, et al. A 300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial. J Allergy Clin Immunol. 2021;147(3):1020-1030.e10
3 Bousquet J, Khaltaev N, Cruz A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008 Apr;63 Suppl 86:8-160.
4 Brozek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines – 2016 revision. J Allergy Clin Immunol. 2017;140(4):950–8
5 Linneberg A., Henrik Nielsen N., Frolund L, et al. The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Allergy Study in Copenhagen. Allergy. 2002 Nov;57(11):1048-1052.
6 Shin JW, Sue JH, Song TW, et al. Atopy and house dust mite sensitization as risk factors for asthma in children. Yonsei Med J. 2005;46: 629-634.
7 Hankin CS, Cox L, Lang D, et al. Allergen immunotherapy and healthcare cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study. Ann Allergy Asthma Immunol. 2010 Jan;104(1):79-85
1714986847
#Stallergenes #Greer #publishes #journal #Lancet #Regional #HealthEurope #large #study #EfficAPSI
Related posts: